Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (61-70 of 345) with videos related to

Pageof 35
Sort By:
RMD Open|October 15, 2025
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA registerEmma Wettersand, Daniela di Giuseppe, Johan Askling, et al.
BMJ (Clinical Research Ed.)|January 30, 2016
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from SwedenPauline Raaschou, Julia F Simard, Charlotte Asker Hagelberg, et al.
Annals of the Rheumatic Diseases|February 22, 2019
Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndromeHelga Westerlind, Marie Holmqvist, Lotta Ljung, et al.
Schizophrenia Bulletin|April 10, 2014
The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risksCarl Sellgren, Thomas Frisell, Paul Lichtenstein, et al.
Rheumatology (Oxford, England)|February 23, 2023
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model applicationAndrei Barbulescu, Arvid Sjölander, Bénédicte Delcoigne, et al.
Journal of Internal Medicine|March 10, 2025
Non-steroidal anti-inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high-use populationsHjalmar Wadström, Johan Askling, Rolf Gedeborg, et al.
Annals of the Rheumatic Diseases|June 24, 2026
Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year studyMaxime Raffray, Helga Westerlind, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|December 17, 2020
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|July 29, 2021
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practiceViking Huss, Hannah Bower, Hjalmar Wadström, et al.
Annals of the Rheumatic Diseases|August 1, 2006
The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomyCecilia Carlens, Lena Brandt, Lars Klareskog, et al.
Pageof 35

Showing results (61-70 of 345) with videos related to

Sort By:
Pageof 35
RMD Open|October 15, 2025
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA registerEmma Wettersand, Daniela di Giuseppe, Johan Askling, et al.
BMJ (Clinical Research Ed.)|January 30, 2016
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from SwedenPauline Raaschou, Julia F Simard, Charlotte Asker Hagelberg, et al.
Annals of the Rheumatic Diseases|February 22, 2019
Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndromeHelga Westerlind, Marie Holmqvist, Lotta Ljung, et al.
Schizophrenia Bulletin|April 10, 2014
The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risksCarl Sellgren, Thomas Frisell, Paul Lichtenstein, et al.
Rheumatology (Oxford, England)|February 23, 2023
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model applicationAndrei Barbulescu, Arvid Sjölander, Bénédicte Delcoigne, et al.
Journal of Internal Medicine|March 10, 2025
Non-steroidal anti-inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high-use populationsHjalmar Wadström, Johan Askling, Rolf Gedeborg, et al.
Annals of the Rheumatic Diseases|June 24, 2026
Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year studyMaxime Raffray, Helga Westerlind, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|December 17, 2020
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|July 29, 2021
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practiceViking Huss, Hannah Bower, Hjalmar Wadström, et al.
Annals of the Rheumatic Diseases|August 1, 2006
The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomyCecilia Carlens, Lena Brandt, Lars Klareskog, et al.
Pageof 35